OPRX News and Press, OptimizeRx Corporation From 03/08/23

2023-03-08 16:04:23 ET OptimizeRx press release ( NASDAQ: OPRX ): Q4 Non-GAAP EPS of $0.25 beats by $0.01 . Revenue of $19.7M (-3.0% Y/Y) misses by $2.07M . For the full year 2023, the company expects net revenues to increase at least 10% year-over-year. T...

Q4 revenue of $19.7 million, down 3% year-over-year and up 30% quarter-over-quarter Q4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63% Generated $10.7 million in cash flow from operations in 2022 Repurchased 1.2 million shares durin...

2023-03-07 17:35:45 ET OptimizeRx ( NASDAQ: OPRX ) is scheduled to announce Q4 earnings results on Wednesday, March 8th, after market close. The consensus EPS Estimate is $0.24 (+9.1% Y/Y) and the consensus Revenue Estimate is $21.77M (+7.2% Y/Y). Over the last 2 years...

2023-03-07 17:35:20 ET Major earnings expected after the bell on Wednesday include: MongoDB ( MDB ) Asana ( ASAN ) Vermilion Energy ( VET ) Assertio Holdings ( ASRT ) Orion Office REIT ( ONL ) For further details see: Notable earnings afte...

Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , March 3, 2023 /PRNewswire/...

ROCHESTER, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, March 8, 2023 at&#x...

ROCHESTER, Mich., Feb. 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced its senior vice president of access and adherence,...

OPRX CEO Will Febbo provides business update and key industry trends OPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich., Jan. 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading ...

ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following...

OptimizeRx Corporation (OPRX) Q3 2022 Earnings Conference Call November 8, 2022 16:30 ET Company Participants Will Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial and Operating Officer Steve Silvestro - Chief Commercial Officer Marion Odence-For...